Search research articles
Contact Us
Filters
Showing results (71-80 of 94) with videos related to
Page
of 10
Sort By:
Advanced Materials (Deerfield Beach, Fla.)
|
September 19, 2022
Approaching the Intrinsic Threshold Breakdown Voltage and Ultrahigh Gain in a Graphite/InSe Schottky Photodetector
Zhiyi Zhang, Bin Cheng, Jeremy Lim, et al.
International Journal of Hematology
|
October 16, 2014
Cdc42 inhibitor ML141 enhances G-CSF-induced hematopoietic stem and progenitor cell mobilization
Chong Chen, Xuguang Song, Sha Ma, et al.
Leukemia Research
|
July 25, 2022
Targeting cyclin-dependent kinases 4/6 inhibits survival of megakaryoblasts in acute megakaryoblastic leukaemia
Kunming Qi, Xueting Hu, Xiangru Yu, et al.
Journal of the American Chemical Society
|
October 25, 2019
Decoupling Ionic and Electronic Pathways in Low-Dimensional Hybrid Conductors
Yubing Zhou, Chaoji Chen, Xin Zhang, et al.
Transplantation and Cellular Therapy
|
December 3, 2021
Absolute Lymphocyte Count Prior to Lymphodepletion Impacts Outcomes in Multiple Myeloma Patients Treated with Chimeric Antigen Receptor T Cells
Yang Liu, Wei Chen, Mingxiao Yu, et al.
International Immunopharmacology
|
March 1, 2021
Caspase-1 inhibition ameliorates murine acute graft versus host disease by modulating the Th1/Th17/Treg balance
Wei Chen, GuiZhen Su, Yan Xu, et al.
Oncology Reports
|
April 23, 2020
TIRC7 inhibits Th1 cells by upregulating the expression of CTLA‑4 and STAT3 in mice with acute graft‑versus‑host disease
Feng Zhu, Tingting Qiu, Shengyun Zhu, et al.
American Journal of Hematology
|
April 11, 2018
Potent anti-leukemia activities of humanized CD19-targeted Chimeric antigen receptor T (CAR-T) cells in patients with relapsed/refractory acute lymphoblastic leukemia
Jiang Cao, Gang Wang, Hai Cheng, et al.
Frontiers in Immunology
|
November 4, 2022
Prolonged hematological toxicity in patients receiving BCMA/CD19 CAR-T-cell therapy for relapsed or refractory multiple myeloma
Hujun Li, Lina Zhao, Zengtian Sun, et al.
Frontiers in Oncology
|
July 1, 2021
An Analysis of Cardiac Disorders Associated With Chimeric Antigen Receptor T Cell Therapy in 126 Patients: A Single-Centre Retrospective Study
Kunming Qi, Zhiling Yan, Hai Cheng, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 94) with videos related to
Sort By:
Page
of 10
Advanced Materials (Deerfield Beach, Fla.)
|
September 19, 2022
Approaching the Intrinsic Threshold Breakdown Voltage and Ultrahigh Gain in a Graphite/InSe Schottky Photodetector
Zhiyi Zhang, Bin Cheng, Jeremy Lim, et al.
International Journal of Hematology
|
October 16, 2014
Cdc42 inhibitor ML141 enhances G-CSF-induced hematopoietic stem and progenitor cell mobilization
Chong Chen, Xuguang Song, Sha Ma, et al.
Leukemia Research
|
July 25, 2022
Targeting cyclin-dependent kinases 4/6 inhibits survival of megakaryoblasts in acute megakaryoblastic leukaemia
Kunming Qi, Xueting Hu, Xiangru Yu, et al.
Journal of the American Chemical Society
|
October 25, 2019
Decoupling Ionic and Electronic Pathways in Low-Dimensional Hybrid Conductors
Yubing Zhou, Chaoji Chen, Xin Zhang, et al.
Transplantation and Cellular Therapy
|
December 3, 2021
Absolute Lymphocyte Count Prior to Lymphodepletion Impacts Outcomes in Multiple Myeloma Patients Treated with Chimeric Antigen Receptor T Cells
Yang Liu, Wei Chen, Mingxiao Yu, et al.
International Immunopharmacology
|
March 1, 2021
Caspase-1 inhibition ameliorates murine acute graft versus host disease by modulating the Th1/Th17/Treg balance
Wei Chen, GuiZhen Su, Yan Xu, et al.
Oncology Reports
|
April 23, 2020
TIRC7 inhibits Th1 cells by upregulating the expression of CTLA‑4 and STAT3 in mice with acute graft‑versus‑host disease
Feng Zhu, Tingting Qiu, Shengyun Zhu, et al.
American Journal of Hematology
|
April 11, 2018
Potent anti-leukemia activities of humanized CD19-targeted Chimeric antigen receptor T (CAR-T) cells in patients with relapsed/refractory acute lymphoblastic leukemia
Jiang Cao, Gang Wang, Hai Cheng, et al.
Frontiers in Immunology
|
November 4, 2022
Prolonged hematological toxicity in patients receiving BCMA/CD19 CAR-T-cell therapy for relapsed or refractory multiple myeloma
Hujun Li, Lina Zhao, Zengtian Sun, et al.
Frontiers in Oncology
|
July 1, 2021
An Analysis of Cardiac Disorders Associated With Chimeric Antigen Receptor T Cell Therapy in 126 Patients: A Single-Centre Retrospective Study
Kunming Qi, Zhiling Yan, Hai Cheng, et al.
Page
of 10